trial

Perceptual Deficits in Schizophrenia

NCTId NCT02337439
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 60 (estimated)
Sponsored by VA Connecticut Healthcare System
Primary completion 2018-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2014-08
Primary completion
2018-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Sensory Information Processing Training

Sponsors

VA Connecticut Healthcare SystemLead Sponsor
Brain & Behavior Research FoundationCollaborator

Sites

1 total
New Haven, United States

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2018-01
Status
UNKNOWN
relationships
The graph out of here
drug
Sensory Information Processing Training
drug
lead_sponsor
VA Connecticut Healthcare System
company
collaborator
Brain & Behavior Research Foundation
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication